(2018) conducted PD-L1 detection with the 22C3 Assay on 10005 NSCLC patients, and the results showed that poorly-differentiated tumor histology and ALK translocation were significantly associated with PD-L1 expression (31). This evidence concerns the gene CD274 and neoplasm.